Quantitative comparison of PD-L1 IHC assays against NIST standard reference material 1934-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Quantitative comparison of PD-L1 IHC assays against NIST standard reference material 1934

Published:2021-08-13 Issue: Volume: Page:
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Sompuram Seshi R.,Torlakovic Emina E.,‘t Hart Nils A.,Vani Kodela,Bogen Steven A.

Funder

Canadian Association of Pathologists

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

https://www.nature.com/articles/s41379-021-00884-w.pdf

Reference34 articles.

1. Taylor, C. Growing pains: from a stain to an assay. Appl. Immunohistochem. Mol. Morphol. 27, 325–326 (2019).

2. Torlakovic, E. et al. Development and validation of measurement traceability for in situ immunoassays. Clin. Chem. 67, 763–771 (2021).

3. Torlakovic, E. et al. “Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy. Mod. Pathol. 33, 4–17 (2020).

4. Tsao, M. et al. PD-L1 immunohistochemistry comparability study in real-life clinical samples: results of Blueprint Phase 2 project. J. Thor. Oncol. 13, 1302–1311 (2018).

5. Hirsch, F. et al. PD-L1 immunohistochemistry assays for lung cancer: results from Phase 1 of the Blueprint PD-L1 IHC assay comparison project. J. Thor. Oncol. 12, 208–222 (2017).

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative comparison of immunohistochemical HER2‐low detection in an interlaboratory study;Histopathology;2024-07-29

2. Towards targeting the breast cancer immune microenvironment;Nature Reviews Cancer;2024-07-05

3. Advances and prospects of biomarkers for immune checkpoint inhibitors;Cell Reports Medicine;2024-07

4. The anti-cancer immune response in breast cancer: current and emerging biomarkers and treatments;Trends in Cancer;2024-06

5. Considerable interlaboratory variation in PD‐L1 positivity for head and neck squamous cell carcinoma in the Netherlands— A nationwide evaluation study;Histopathology;2024-04-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3